Trials / Completed
CompletedNCT03207282
Treatment Resistant Depression in America Latina
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,539 (actual)
- Sponsor
- Janssen-Cilag, S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the prevalence of Treatment Resistant Depression (TRD) among Major Depressive Disorder (MDD) participants being treated in a psychiatry reference site (example, clinic, ambulatory, hospital, day-hospital) in 4 Latin American countries: Argentina, Brazil, Colombia and Mexico; and to evaluate all and depression-related healthcare resource utilization in TRD participants.
Conditions
Timeline
- Start date
- 2017-09-27
- Primary completion
- 2019-11-25
- Completion
- 2019-11-25
- First posted
- 2017-07-02
- Last updated
- 2025-04-27
Locations
33 sites across 4 countries: Argentina, Brazil, Colombia, Mexico
Source: ClinicalTrials.gov record NCT03207282. Inclusion in this directory is not an endorsement.